SecProbe.io

CORRESP
1
filename1.htm

August 15, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, NE

Washington, D.C. 20549

Attention: Benjamin Richie

    Re:
    NeuroOne Medical Technologies Corporation

    Registration Statement on Form S-3

    File No. 333-279871

    Acceleration Request

    Requested Date:
    August 16, 2024

    Requested Time:
    4:05 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, NeuroOne Medical Technologies Corporation (the “Company”) hereby respectfully
requests that the above-referenced Registration Statement on Form S-3 (File No. 333-279871) (as amended, the “Registration Statement”)
be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable
thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of
Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of Emily J. Johns and Emphani A. Aldridge
of Honigman LLP, counsel to the Company, to make such request on its behalf.

Please confirm the effectiveness
of the Registration Statement with Emily J. Johns of Honigman LLP by telephone at (616) 649-1908 or Emphani A. Aldridge of Honigman LLP
by telephone at (313) 465-8224.

[Signature page follows]

****

  Sincerely,

  NeuroOne Medical Technologies corporation

  /s/ Dave Rosa

  Dave Rosa

  Chief Executive Officer

  cc:
  Emily J. Johns, Honigman LLP

  Emphani A. Aldridge, Honigman LLP